Sleep Related Questionnaires

HomeMembersAssemblies and SectionsAssembliesSleep and Respiratory NeurobiologySleep Related Questionnaires ▶ Augmentation Severity Rating Scale (ASRS)
Augmentation Severity Rating Scale (ASRS)

Name of questionnaire Augmentation Severity Rating Scale (ASRS)
Type of questionnaire-description,age Quantitative measure of the severity of augmentation (i.e. worsening of restless legs syndrome symptoms during treatment). To be
used at baseline and then administered prospectively with treatment.
Number of items 3
Number of domains /categories 3
Name of categories/domains   Not applicable
Scaling of items 0-8 per item
Scoring available: with permission or free 0-24 0=no augmentation, 24= very severe augmentation
Scoring test-retest reliability Yes, rho=0.72
Scoring Internal consistency Yes, Cronbach's alpha = 0.62
Validity Yes, assessed by the correlation between the worst ASRS total score and the expert rating
Available forms (short and/or long etc.) N/A
Language English
Translations in other languages (if yes, then list the languages) Czech Dutch, Finnish, German, Italian, Polish, Spanish, Swedish
Developer name The European Restless Legs Syndrome Study Group (EURLSSG)
Developer contact information Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon, France
Telephone: +33 (0)4 72 13 65 75
Fax: +33 (0)4 72 13 55 73
Availability of questionnaire: needs permission from developer, cost or freely available Use with permission from Mapi Research Trust, free for academic research studies not connected to a for profit study
Limitations Needs interviewer expertise-i.e. skilled clinician interpretation
Link to the questionnaire (if available) https://eprovide.mapi-trust.org/instruments/augmentation-severity-rating-scale
Other comments Use prior to start of dopaminergic therapy. Helps to establish baseline.
Patient populations in who questionnaire has been validated
References (including original publication, validity and reliability in different countries/languages, populations and long/short versions) 1. Garcia-Borreguero, R. Kohnen, B Hogl, L Ferini-Strambi, G Hadjigeorgiou, M Hornyak, A W de Weerd, S Happe, K Stiasny-Kolster, V Gschliesser, R Egatz, B Cabrero, B Frauscher, C Trenkwalder, W Hening, R Allen. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Medicine 8 (2007) 455-463.
2. Hogl B, Garcia-Borreguero D, Kohnen R, Ferini-Strambi L, Hadjigeorgiou G, Hornyak M, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol. 2010 Sep 11;257(2):230-7
Updated by Rosemarie Beckford, MD
The last date of update December 2016
Last Reviewed: January 2017